why choose us

Clinical Trials Search

Showing 11,960 of 132,366 result(s)
Long-Term Sequelae of SARS-COV-2 Infection: Diabetes Mellitus

Status: Completed

Condition: COVID-19

Interventions: Participants will have hepatic muscle and adipose tissue insulin sensitivity tested

Date: 2023-05-17

Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed;Refractory Hematological Malignancies

Status: NOT_YET_RECRUITING

Condition: Hematologic Malignancy

Interventions: Autologous hematopoietic stem cells (aHSCs) infused on Day 10 after CAR T (any FDA-approved CAR T product) infusion on Day 0.

Date: 2023-05-17

LINNOVATE: Lurbinectedin, Ipilimumab and Nivolumab for Soft Tissue Sarcoma

Status: Completed

Condition: Advanced Soft-tissue Sarcoma

Interventions: This is an open label, dose-seeking phase 1;2 study using escalating doses of LURBINECTEDIN administered intravenously with fixed doses of IPILIM

Date: 2023-05-17

Flashed Light Therapy for Adolescents With ADHD and Delayed Sleep Timing

Status: ACTIVE_NOT_RECRUITING

Condition: ADHD

Interventions: Light flashes will be presented over 60 minutes as 3-millilisecond flashes of white light at 4,000 lux every 20 seconds

Date: 2023-05-17

EPI-MINN: Targeting Cognition and Motivation - National

Status: Completed

Condition: Psychosis

Interventions:

The Cognitive Training Module is designed to improve the speed and accuracy of auditory information processing while engaging working memory and co

Date: 2023-05-17

A Phase 1 Trial to Investigate the Biological Equivalence of 5 × 10 mg Tablets and 2 × 25 mg Tablets of Daridorexant in Healthy Male and Female Japanese Participants

Status: COMPLETED

Condition: Healthy

Interventions: Daridorexant will be available as film-coated tablets for oral administration formulated at strengths of 10 mg.

Date: 2023-05-17

A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013)

Status: Completed

Condition: Non-alcoholic Fatty Liver Disease

Interventions: Subcutaneous (SC) injection in dose-escalation regimens potentially including doses of 2 mg, 4 mg, 7 mg, and 10 mg

Date: 2023-05-17

Evaluation of Comprehensive Geriatric Assessment and Laboratory Biomarkers in Elderly Patients With Multiple Myeloma

Status: Completed

Condition: Plasma Cell Myeloma

Interventions: Undergo blood sample collection

Date: 2023-05-17

Real-World Data Study to Understand Participant Treatment Outcomes for Dupuytren's Contracture

Status: Completed

Condition: Dupuytren's Contracture

Interventions:

Date: 2023-05-17

Non-invasive Brain Stimulation for Treating Symptomatic Convergence Insufficiency

Status: Completed

Condition: Convergence Insufficiency

Interventions: Non-invasive brain stimulation will involve the use of anodal transcranial direct current stimulation to apply a 2 milliamp current over the left fron

Date: 2023-05-17